These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2031995)

  • 41. Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs.
    Garrett ER; Chandran VR
    Biopharm Drug Dispos; 1990; 11(4):311-50. PubMed ID: 2340348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Height-independent estimation of glomerular filtration rate in children: an alternative to the Schwartz equation.
    Blufpand HN; Westland R; van Wijk JA; Roelandse-Koop EA; Kaspers GJ; Bökenkamp A
    J Pediatr; 2013 Dec; 163(6):1722-7. PubMed ID: 24094878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of non-linear models to describe the lactation curves for milk yield and composition in buffaloes (Bubalus bubalis).
    Ghavi Hossein-Zadeh N
    Animal; 2016 Feb; 10(2):248-61. PubMed ID: 26354679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal.
    Wijnand HP
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):109-28. PubMed ID: 3373416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.
    Wang YM; Reuning RH
    Pharm Res; 1992 Feb; 9(2):169-77. PubMed ID: 1553336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An empirical approach to model selection through validation for censored survival data.
    Choi I; Wells BJ; Yu C; Kattan MW
    J Biomed Inform; 2011 Aug; 44(4):595-606. PubMed ID: 21335102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statistical evaluation of diffusion-weighted imaging of the human kidney.
    Wittsack HJ; Lanzman RS; Mathys C; Janssen H; Mödder U; Blondin D
    Magn Reson Med; 2010 Aug; 64(2):616-22. PubMed ID: 20665805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT).
    Yamaoka K; Kanba M; Toyoda Y; Yano Y; Nakagawa T
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):545-59. PubMed ID: 2280349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic analyses with RUGFIT: an interactive pharmacokinetic computer program.
    Scaf AH
    Biopharm Drug Dispos; 1988; 9(5):415-46. PubMed ID: 3224161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    Manikis GC; Marias K; Lambregts DMJ; Nikiforaki K; van Heeswijk MM; Bakers FCH; Beets-Tan RGH; Papanikolaou N
    PLoS One; 2017; 12(9):e0184197. PubMed ID: 28863161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended least squares curve fitting: a comparison of SIPHAR and MKMODEL.
    Cockshott ID; Haywood J
    Biopharm Drug Dispos; 1992 Aug; 13(6):461-80. PubMed ID: 1391682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.
    Yamaoka K; Tanaka H; Okumura K; Yasuhara M; Hori R
    J Pharmacobiodyn; 1986 Feb; 9(2):161-73. PubMed ID: 3754893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Equations to describe brain size across the continuum of human lifespan.
    Borzage M; Blüml S; Seri I
    Brain Struct Funct; 2014 Jan; 219(1):141-50. PubMed ID: 23239013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The time-profile of cell growth in fission yeast: model selection criteria favoring bilinear models over exponential ones.
    Buchwald P; Sveiczer A
    Theor Biol Med Model; 2006 Mar; 3():16. PubMed ID: 16566825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of Zero-Inflated Regression Models in a Large-Scale Population Survey of Sub-Health Status and Its Influencing Factors.
    Xu T; Zhu GJ; Han SM
    Chin Med Sci J; 2017 Dec; 32(4):218-225. PubMed ID: 29301596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.
    Grubb A; Nyman U; Björk J; Lindström V; Rippe B; Sterner G; Christensson A
    Clin Chem; 2005 Aug; 51(8):1420-31. PubMed ID: 15961546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simulating pharmacokinetic and pharmacodynamic fuzzy-parameterized models: a comparison of numerical methods.
    Seng KY; Nestorov I; Vicini P
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):595-621. PubMed ID: 17710517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Note: caution in use of empirical equations for pharmacodynamic indirect response models.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Biopharm; 1998 Dec; 26(6):735-41. PubMed ID: 10485083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A primer on model selection using the Akaike Information Criterion.
    Portet S
    Infect Dis Model; 2020; 5():111-128. PubMed ID: 31956740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.